8SBC
Co-structure of Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform and brain penetrant inhibitors
8SBC の概要
エントリーDOI | 10.2210/pdb8sbc/pdb |
分子名称 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, Phosphatidylinositol 3-kinase regulatory subunit alpha, (2M)-7-[(3R)-3-methylmorpholin-4-yl]-5-[(3S)-3-methylmorpholin-4-yl]-2-(pyridin-2-yl)-1H-imidazo[4,5-b]pyridine, ... (5 entities in total) |
機能のキーワード | lipid kinase, mutant, p85, nish2, brain-penetrant, mtor, transferase |
由来する生物種 | Homo sapiens (human) 詳細 |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 160921.16 |
構造登録者 | |
主引用文献 | Bonazzi, S.,Gray, A.,Thomsen, N.M.,Biag, J.,Labbe-Giguere, N.,Keaney, E.P.,Malik, H.A.,Sun, Y.,Nunez, J.,Karki, R.G.,Knapp, M.,Elling, R.,Fuller, J.,Pardee, G.,Craig, L.,Capre, K.,Salas, S.,Gorde, A.,Liang, G.,Lubicka, D.,McTighe, S.M.,Goold, C.,Liu, S.,Deng, L.,Hong, J.,Fekete, A.,Stadelmann, P.,Frieauff, W.,Elhajouji, A.,Bauer, D.,Lerchner, A.,Radetich, B.,Furet, P.,Piizzi, G.,Burdette, D.,Wilson, C.J.,Peukert, S.,Hamann, L.G.,Murphy, L.O.,Curtis, D. Identification of Brain-Penetrant ATP-Competitive mTOR Inhibitors for CNS Syndromes. J.Med.Chem., 66:9095-9119, 2023 Cited by PubMed Abstract: The allosteric inhibitor of the mechanistic target of rapamycin (mTOR) everolimus reduces seizures in tuberous sclerosis complex (TSC) patients through partial inhibition of mTOR functions. Due to its limited brain permeability, we sought to develop a catalytic mTOR inhibitor optimized for central nervous system (CNS) indications. We recently reported an mTOR inhibitor () that is able to block mTOR functions in the mouse brain and extend the survival of mice with neuronal-specific ablation of the 1 gene. However, showed the risk of genotoxicity . Through structure-activity relationship (SAR) optimization, we identified compounds and without genotoxicity risk. In neuronal cell-based models of mTOR hyperactivity, both corrected aberrant mTOR activity and significantly improved the survival rate of mice in the 1 gene knockout model. Unfortunately, and showed limited oral exposures in higher species and dose-limiting toxicities in cynomolgus macaque, respectively. However, they remain optimal tools to explore mTOR hyperactivity in CNS disease models. PubMed: 37399505DOI: 10.1021/acs.jmedchem.3c00705 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.3 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード